Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by investclubon Nov 14, 2019 8:42am

112 Views

Post# 30349576

RE:Interesting data point...

vestor111 wrote
I just opened up an email that had this data point about biotech investing:

"As a result, we've had a different biotech stock taken over every 56 days..."

Hi vestor111.. I hope we don't see a take-over too earlier in PH2 as you are aware the closer to end results would bring in a significantly higher offer and of course should this go the full length other indications would cause multi bids. Not saying we could see historic big pharmas trying to out bid each other just simply implying it might be a reasonable outcome.

Bullboard Posts

Unique Battery Metals opportunity in Quebec